Daniel Griffin, MD

Daniel Griffin, MD

Specialty: Infectious Disease
Book An Appointment
Insurance plans   |   Patient Forms
Accepting New Patients
loading...
Locations
Infectious Diseases - Lake Success

1 Dakota Drive Suite 218
Lake Success, NY 11042

1-516-656-6500
Learn more
  • About
  • Education & Training
  • Affiliations
  • Publications
About
About Provider Daniel Griffin, MD:

Dr. Daniel Griffin is a physician-scientist, board certified in internal medicine and infectious disease with decades of experience. He is an active clinician and internationally-invited speaker lecturing for multiple organizations, including the University of Glasgow, the Peace Corps, University of Minnesota, Foundation for International Medical Relief of Children, Floating Doctors, and Remote Care Education, as well as for other groups in Asia, the Caribbean, Central America, Africa, and India. Dr. Griffin is also one of the co-hosts of the popular 5-star rated podcasts: This Week in Parasitism and This Week in Virology, and is always ready to listen to and advocate for his patients, even after others have found the diagnosis challenging or evasive.

Show More
Languages Spoken: English
Gender: Male
Articles and Videos:

Virology expert talks flu season, Adderall shortage, and new research on global epidemic of cancer for those younger than 50

Patient Ratings and Comments

The following reviews are from real patients who had a recent visit with this provider:

loading...
Education & Training
Awards & Recognitions:
  • Awards:
  • First Place Lawrence Scherr Award for Scholarly Activity: 2014
  • First Place Basic Science Category Infectious Disease Society of New York: 2014
  • Second Place Lawrence Scherr Award for Scholarly Activity: 2013
  • Ruth and Leonard Litwin Fellowship Award: 2011
  • Malcolm Baldridge National Quality Award: 2008
  • Davies Award: 2006
  • Denver Business Journal Physician Champion Award: 2007
  • DOQ-IT Best Practice Award: 2005
  • CMS Award: 2005
  • NYU School of Medicine Independent Research Project Award: 1995
  • Recognition:
  • First Transformational Grand Rounds Colorado Foundation for Medical CareCMS speaker for the
  • Medical Records Institute (Host of TEPR) speaker for the EMR Road Show
Training:
  • Medical Education
    • New York University School of Medicine: 1998
  • Internship
    • Univ of Utah Hosp and Clinics
  • Fellowship
    • Univ of Utah Hosp and Clinics
  • Board Certifications
    • American Board of Internal Medicine
Affiliations
Hospital Affiliations:
  • New York Presbyterian Columbia University Medical Center-Consultation Privileges 712015-Current 630 West 168th Street New York, NY 10032 North Shore University Hospital-Infectious Disease Consultation Privileges 9162009-6302013, 12017-current 300 Community Dr, Manhasset NY 11030 Medical Staff Office (516)-823-8855 Long Island Jewish Hospital- Infectious Disease Consultation Privileges 9162009-6302013, 2172015-112015, 1-2017-current 270-05 76th Ave, New Hype Park, NY 11040 Medical Staff Office (516)-823-8855 Plainview Hospital Infectious Disease Consultation Privileges 12017-current 888 Old Country Road, Plainview, NY 11803 Medical Staff Office (516)-823-8855 Syosset Hospital Infectious Disease Consultation Privileges 12017-current 221 Jericho Turnpike, Syosset, NY 11791 Medical Staff Office (516)-823-8855 LIJ-Valley Stream Hospital Infectious Disease Consultation Privileges 11142017-current 900 Franklin Ave, Valley Stream, NY 11580 Medical Staff Office (516)-823-8855 Saint Francis Hospital 07242018 -current 100 Port Washington Boulevard Roslyn, NY 11576 Medical Staff Office (516)-562-6000 Saint Joseph Hospital 06162020-current 4295 Hempstead Turnpike Bethpage, NY 11714 Medical Staff Office (516)-520-2387
Professional Affiliations:
  • Lifetime member of American Medical Association
  • Member of the American Association for the Advancement of Science
  • Member of the Infectious Diseases Society of America
  • Member of American Society of Tropical Medicine and Hygiene
  • Member of the International Society for Travel Medicine
  • Member of American Society of Parasitologists
  • Lifetime member of Wilderness Medical Society
Publications

1. Gabriel Johnson; Sarah Lim; Daniel O Griffin; Xiong Wang; Lida R Etemad, The Impact or COVID-19 Monoclonal Antibody Therapy on Progression to Hospitalization in A Population with a High Percentage of the SARS-CoV-2 Alpha Variant. Medical Research Archives Feb 2022 vol 10 issue 2.

2. Cuker, A., E. K. Tseng, R. Nieuwlaat, P. Angchaisuksiri, C. Blair, K. Dane, J. Davila, M. T. DeSancho, D. Diuguid, Griffin D. O., S. R. Kahn, F. A. Klok, A. I. Lee, I. Neumann, A. Pai, M. Righini, K. M. Sanfilippo, D. Siegal, M. Skara, D. R. Terrell, K. Touri, E. A. Akl, R. N. Al Jabiri, Y. N. Al Jabiri, A. M. Barbara, A. Bognanni, I. Bou Akl, M. Boulos, R. Brignardello-Petersen, R. Charide, M. Chan, L. E. Colunga-Lozano, K. Dearness, A. J. Darzi, H. Hussein, S. G. Karam, P. Kolb, R. Mansour, G. P. Morgano, R. Z. Morsi, G. Muti-Sch?nemann, M. K. Nadim, A. Noori, B. A. Philip, T. Piggott, Y. Qiu, Y. R. Benitez, F. Sch?nemann, A. Stevens, K. Solo, W. Wiercioch, R. A. Mustafa and H. J. Sch?nemann (2022) American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Blood Advances, Jan 21, 2022, 6, 664-671.

3. Johnson G, Lim S, Griffin DO, Wang X, Etemad LR. The Impact of COVID-19 Monoclonal Antibody Therapy on Progression to Hospitalization in A Population with a High Percentage of the SARS-CoV-2 Alpha Variant. JMRA Jan 2022 in press.

4. Cuker, A., E. K. Tseng, R. Nieuwlaat, P. Angchaisuksiri, C. Blair, K. Dane, J. Davila, M. T. DeSancho, D. Diuguid, D. O. Griffin, S. R. Kahn, F. A. Klok, A. I. Lee, I. Neumann, A. Pai, M. Pai, M. Righini, K. M. Sanfilippo, D. Siegal, M. Skara, K. Touri, A. A. E, I. Bou Akl, M. Boulos, R. Brignardello-Petersen, R. Charide, M. Chan, K. Dearness, A. J. Darzi, P. Kolb, L. E. Colunga-Lozano, R. Mansour, G. P. Morgano, R. Z. Morsi, A. Noori, T. Piggott, Y. Qiu, Y. Roldan, F. Schunemann, A. Stevens, K. Solo, M. Ventresca, W. Wiercioch, R. A. Mustafa and H. J. Schunemann (2021) American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv, Oct 14, 2021, 5, 872-888.

5. Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid DL, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Righini M, Sanfilippo K, Siegal DM, Skara M, Terrell DR, Touri K, Akl EA, Al Jabiri RN, Al Jabiri YN, Barbara AM, Bognanni A, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Colunga-Lozano LE, Dearness KL, Darzi AJ, Hussein H, Karam SG, Kolb P, Mansour R, Morgano GP, Morsi RZ, Muti-Sch?nemann G, Nadim MK, Noori A, Philip BA, Piggott T, Qiu Y, Benitez YR, Sch?nemann F, Stevens A, Solo K, Wiercioch W, Mustafa RA, Sch?nemann HJ. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis. Blood Adv. 2021 February 28, 2021:bloodadvances.2021005945. doi: 10.1182bloodadvances.2021005945. PMID: 34727173. https:pubmed.ncbi.nlm.nih.gov34727173